New Zealand markets open in 4 hours 38 minutes

Shanghai MicroPort Endovascular MedTech Co., Ltd. (688016.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
98.05-0.43 (-0.44%)
At close: 03:00PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 12.09B
Enterprise value 8.94B
Trailing P/E 19.99
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.69
Price/book (mrq)2.99
Enterprise value/revenue 7.10
Enterprise value/EBITDA 13.84

Trading information

Stock price history

Beta (5Y monthly) 0.33
52-week change 3-18.41%
S&P500 52-week change 322.55%
52-week high 3141.14
52-week low 397.13
50-day moving average 3115.51
200-day moving average 3121.57

Share statistics

Avg vol (3-month) 31.34M
Avg vol (10-day) 31.54M
Shares outstanding 5123.26M
Implied shares outstanding 6123.26M
Float 866.16M
% held by insiders 142.41%
% held by institutions 114.34%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 43
Forward annual dividend yield 43.06%
Trailing annual dividend rate 32.01
Trailing annual dividend yield 32.04%
5-year average dividend yield 4N/A
Payout ratio 431.46%
Dividend date 3N/A
Ex-dividend date 414 May 2024
Last split factor 21.49:1
Last split date 314 May 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 43.81%
Operating margin (ttm)57.42%

Management effectiveness

Return on assets (ttm)11.15%
Return on equity (ttm)18.35%

Income statement

Revenue (ttm)1.26B
Revenue per share (ttm)11.28
Quarterly revenue growth (yoy)25.40%
Gross profit (ttm)N/A
EBITDA 616.83M
Net income avi to common (ttm)551.89M
Diluted EPS (ttm)4.90
Quarterly earnings growth (yoy)47.60%

Balance sheet

Total cash (mrq)3.18B
Total cash per share (mrq)25.78
Total debt (mrq)32.87M
Total debt/equity (mrq)0.80%
Current ratio (mrq)10.06
Book value per share (mrq)32.80

Cash flow statement

Operating cash flow (ttm)650.86M
Levered free cash flow (ttm)273.57M